Supernus Pharmaceuticals Inc (SUPN)
Retained Earnings
$457.21M
Quarterly · Period ending: · USD
SUPN Retained Earnings
Latest reported$457.21Mperiod ending
Latest reported$457.21Mperiod ending
SUPN Quarterly Retained Earnings (-$55.32M → $457.21M)
Quarterly retained earnings
High-resolution chart · PNG
SUPN retained earnings history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Retained Earnings (USD) |
|---|---|
| 457,212,000 | |
| 515,582,999 | |
| 517,876,000 | |
| 521,981,000 | |
| 567,098,000 | |
| 544,599,000 | |
| 556,426,000 | |
| 541,098,000 | |
| 502,601,000 | |
| 482,685,000 | |
| 482,561,000 | |
| 481,386,000 | |
| 497,362,000 | |
| 498,193,000 | |
| 481,245,000 | |
| 455,764,000 | |
| 454,015,000 | |
| 446,150,000 | |
| 379,922,000 | |
| 377,480,000 | |
| 355,918,000 | |
| 332,192,000 | |
| 326,498,000 | |
| 295,730,000 | |
| 255,733,000 | |
| 221,066,000 | |
| 199,548,000 | |
| 166,419,000 | |
| 137,559,000 | |
| 104,832,000 | |
| 86,492,000 | |
| 60,599,000 | |
| 32,588,000 | |
| 1,851,000 | |
| -26,823,000 | |
| -40,481,000 | |
| -56,442,000 | |
| -73,810,000 | |
| -84,288,000 | |
| -98,607,000 | |
| -129,636,000 | |
| -139,654,000 | |
| -144,641,000 | |
| -151,512,000 | |
| -155,734,000 | |
| -157,740,000 | |
| -158,657,000 | |
| -163,012,000 | |
| -190,870,000 | |
| -194,071,000 | |
| -178,528,000 | |
| -156,122,000 | |
| -132,026,000 | |
| -104,669,000 | |
| -86,255,000 | |
| -72,742,000 | |
| -59,259,000 | |
| -49,247,000 | |
| -39,971,000 | |
| -121,947,000 | |
| -93,786,000 | |
| -85,209,726 | |
| -55,323,000 |